We compared the effects on plasma lipids of margarines containing either a trans fatty acid-(TFA)-free hard fraction achieved through interesterification (from primarily saturated fatty acids) or a partially hydrogenated hard fraction. Thirty-eight mildly hyperlipidemic subjects consumed a low-fat diet for 2 wk. They were then allocated to 2 groups and underwent 3 dietary interventions for 3 wk each in random order (diets contained 35% of energy as fat with 20% of energy as margarines or butter): group 1 (n = 18), butter, canola oil blend with TFAs, and TFA-free canola oil blend; group 2 (n = 19), butter, polyunsaturated oil blend with TFAs, and TFA-free polyunsaturated oil blend. Plasma LDL-cholesterol concentrations after consumption of all oil blends and after the low-fat diet were not significantly different, but were 11-15% lower than after butter (P < 0.001). Whereas the canola oil blends did not differ from each other in their effects on lipoprotein profiles, the TFA-free polyunsaturated oil blend resulted in a significant 6% reduction (Ϫ0.25 mmol/L; 95% CI: Ϫ0.08, Ϫ0.42) in total and LDL cholesterol compared with the blend containing TFAs (P = 0.006). In the canola oil blend, 10% TFAs and 6% oleic acid were replaced by Ϸ14% saturated fatty acids plus a 2% increase in linoleic acid. In the polyunsaturated oil blend, 10% TFAs and 5% linoleic acid were replaced by a 10% increase in saturated fatty acids as well as 3% and 1% increases in oleic and linolenic acids, respectively. We conclude that, compared with butter, TFA-free margarines may be equal to or more effective than margarines containing TFAs in lowering LDL cholesterol.
INTRODUCTION
There is wide consensus that lowering plasma LDL cholesterol lowers the risk of coronary artery disease and slows the progression of atherosclerosis (1, 2) . The percentage of energy derived from saturated fatty acids in the food supply has been shown to be strongly associated with mean population serum cholesterol concentrations and coronary artery disease incidence whereas polyunsaturated fatty acid (PUFA) and monounsaturated fatty acid (MUFA) intakes show no such association (3) . There has been controversy surrounding the safety of trans fatty acids (TFAs), which result from the partial hydrogenation of edible oils (4) (5) (6) . Although TFAs are known to raise plasma LDL cholesterol (7, 8) and lower plasma HDL cholesterol (7, 9) relative to unsaturated fatty acids, their potential adverse health effects have been disputed (10, 11) . Furthermore, unsaturated oil blends containing moderate amounts of TFAs have been shown to be lipid lowering when compared with saturated fatty acids (12) .
The hard fraction added to liquid oils in the manufacture of margarine is generally composed of partially hydrogenated fats that contain variable amounts of TFAs. An alternative approach is to use a hard fraction derived through the interesterification of oils, whereby the rearrangement of fatty acids within triacylglycerol molecules changes their physical characteristics. Because in animals the structure of the triacylglycerol may influence cholesterol metabolism, one of the perceived constraints of this strategy is the possibility that the process of interesterification may increase the likelihood of that fat raising plasma LDL concentrations more than the native oil (13) . However, recent studies in humans showed that this does not occur, at least with the oil blends tested (14, 15) .
The aim of this study was to establish whether margarines consisting of oils plus a TFA-free hard fraction achieved through interesterification were at least as effective as their counterparts containing partially hydrogenated fats in lipid lowering when compared with butter. We hypothesized that because TFAs were essentially being replaced by saturated fatty acids, there would be no difference between oil blends with or without TFAs.
SUBJECTS AND METHODS

Subjects
Forty-one free-living subjects with mild hypercholesterolemia (total cholesterol concentration > 5.0 mmol/L) were recruited by advertisement. Subjects who had liver or renal disease, who were taking medication likely to affect lipid metabolism, who consumed > 40 g ethanol/d, or who smoked heavily (> 20 cigaOil blends containing partially hydrogenated or interesterified fats: differential effects on plasma lipids 1,2 rettes/d) were excluded. Those with dietary patterns or lifestyles that precluded them from following the dietary protocol were also excluded. Thirty-eight subjects (17 women and 21 men) completed the dietary intervention study. Three withdrew because of work or travel commitments. All except 2 women in each group were postmenopausal. The study was approved by the CSIRO Division of Human Nutrition Human Ethics Committee and informed, written consent was obtained from the volunteer subjects.
Study design
The subjects took part in an 11-wk dietary trial. All subjects were advised to consume a low-fat diet (< 25% fat energy) for the first 2 wk. They were subsequently randomly allocated to 2 groups of equal number with the following 3-wk intervention periods: group 1, butter, canola oil blend with TFAs, and TFAfree canola oil blend, and group 2, butter, polyunsaturated oil blend with TFAs, and TFA-free polyunsaturated oil blend. The sequence of diets within groups 1 and 2 was randomized; there were 6 possible treatment sequences.
The retrospective characteristics of the 2 groups at screening (Table 1) indicated that the groups did not differ significantly with respect to plasma total cholesterol, age, or body mass index. Fasting blood samples were taken on 2 consecutive occasions at the end of the baseline period and at the end of each of the dietary treatments and the lipid values in each test period were averaged.
Experimental oil blends
The oil blends were typical of margarines available commercially and were supplied by FLORAfoods, Sydney. The margarines were composed predominantly of canola or sunflower oil (Ϸ75%) mixed with 1 of 2 different hardstocks. One hardstock consisted of partially hydrogenated canola oil and contained TFAs. The other hardstock was TFA free and was achieved through interesterification of palmolein and fully hydrogenated vegetable oils, which contributed the additional lauric and myristic acids to the final oil blends. The blends were in the form of a tub margarine and were indistinguishable in terms of their physical and sensory properties.
Diets
All diets during the test periods consisted of a low-fat, background diet that was similar throughout plus the test spreads, which were provided in the form of shortbread biscuits and as a spread that differed according to the intervention period. During each intervention period (excluding baseline), subjects were provided with the test blends as 20% of energy (adjusted according to sex and physical activity). Background diets were held constant in total fat (Ϸ15% fat energy) and were obtained from a combination of self-selected foods of known fat content such as meat and dairy products. Low-fat frozen meals (< 10 g fat/meal) were provided for Ϸ3 meals/wk to facilitate meal planning. Subjects collected their test foods at the beginning of each intervention from the nutrition clinic. The fatty acid composition of the butter and the test oil blends is shown in Table 2 .
All subjects were instructed in the dietary protocol by a dietitian (MN) and were interviewed twice during each 4-wk period. They were advised to document and quantify their fat intake daily and to restrict it to < 40 g by using a commercial fat counter. Subjects kept detailed weighed food records of all foods consumed for 3 consecutive days (Sunday, Monday, and Tuesday) of each test diet and were provided with electronic scales for this purpose. Daily and 3-d diet records were reviewed extensively by the research dietitian to ensure that they were complete and that they were compatible with that individual's planned fat intake. Specific advice was given to avoid other spreads and oils as well as foods or nutritional supplements that may have independent effects on plasma lipids and to maintain a similar pattern of eating throughout the study.
A total of 12 d of detailed food records was kept for each subject and subsequently analyzed. Nutrient intakes ( Table 3) were calculated with DIET/1 Nutrient Calculation Software (Xyris Software, Highgate Hill, Australia), a computer database of foods in which nutrient composition was based on Australian foods, and which we modified to include data from commercial sources and analyses of the test oil blends.
Measurements
Venous blood samples (10 mL) were taken after an overnight fast of ≤ 12 h into tubes containing Na 2 EDTA (1 g/L final concentration) as an anticoagulant. Plasma was separated by low-speed centrifugation (GS-6R centrifuge; Beckman, Fullerton, CA) at 2060 ϫ g for 10 min at room temperature and aliquots were frozen at Ϫ20ЊC. At the end of the study, all samples from each subject were analyzed within the same analytic run. Total cholesterol (16) and triacylglycerol (17) concentrations were measured on a Cobas-Bio centrifugal analyzer (Roche Diagnostica, Basel, Switzerland) by using enzymatic kits (Roche Diagnostica) and control sera. Plasma HDL-cholesterol concentrations were measured after precipitation of LDL and VLDL with a polyethylene glycol 6000 solution (18) . The following modification of the Friedewald equation (19) for molar concentrations was used to calculate LDL cholesterol in mmol/L: total cholesterol Ϫ triacylglycerol/2.18 Ϫ HDL cholesterol.
The fatty acids in the test fats were quantified by gas chromatography with a 5711 gas chromatograph (Hewlett Packard, Avondale, PA) with a 30 m ϫ 0.5 mm BPX-70 capillary column (SGE Pty Ltd, Melbourne) (20) . Total TFAs were quantified on an 8500 gas chromatograph (Dani, Dani, Italy) with a 100 m ϫ 0.2 mm BPX-70 column with use of a controlled temperature program (140 ЊC for 30 s, then increments of 0.9 ЊC/min to 210 ЊC, and then 210 ЊC for 12.5 min).
Statistical analysis
Data were analyzed by repeated-measures analysis of variance within each group for diet effects with order and sex as betweensubject factors by using the SPSS PC+ statistical package (SPSS Inc, Chicago). When the analysis indicated significant differences among the diets, paired t tests were used to locate significant differences. Differences between groups 1 and 2 were compared with unpaired t tests. P values < 0.01 were considered to be statistically significant. Our sample size within groups enabled us to detect 0.27-mmol/L and 0.11-mmol/L changes in LDL and HDL cholesterol, respectively, between margarines, with 80% power at P < 0.05. Between groups, we had sufficient power to detect a difference in LDL cholesterol of 0.34 mmol/L.
RESULTS
Body weights were measured at each clinic visit and remained unchanged throughout the study. In group 1 weights (x -± SD) were 79.9 ± 14.4, 79.4 ± 14.6, 79.9 ± 14.3, and 79.4 ± 15.1 kg and in group 2 they were 73.6 ± 13.4, 73.5 ± 13.6, 73.5 ± 13.6, and 73.5 ± 13.6 kg at the end of the low-fat, butter, oil blend with TFAs, and TFA-free oil blend intervention periods, respectively. Dietary intake data (Table 3) showed that the fatty acid profiles of the diets reflected those of the test foods. Importantly, energy and macronutrient compositions did not differ between the butter and oil blend intervention periods. The broad fatty acid profiles (PUFAs, MUFAs, and saturated fatty acids) in the TFA and TFA-free oil blends were also not significantly different; however, the TFA and TFA-free blends did differ from butter in dietary cholesterol (P < 0.01) and saturated fatty acids and PUFAs (P < 0.01). In contrast with the polyunsaturated oil group (group 2), in which total MUFA intake was not significantly different between the oil blend and butter interventions, there was a significant difference in MUFA intake in the canola oil group between the oil blend and butter interventions (P < 0.001). Australian food databases do not include values for TFAs, which are included in the data for MUFAs. However, TFA intakes can be approximated from the measured amounts in the oil blends and the dietary prescription. An additional 2% and 1% of energy from TFAs was provided by the TFA blends and butter, respectively, with the background diet providing a further 1% of energy for all diets.
The lipid results for each group are presented in Table 4 . Plasma total and LDL cholesterol were lower with all oil blends than with butter (P < 0.001). The TFA-free polyunsaturated oil blend resulted in a significant 0.25-mmol/L reduction in LDL-cholesterol concentration (95% CI: Ϫ0.08, Ϫ0.42 mmol/L) compared with the blend containing TFAs (P = 0.006). However, there was no significant difference in LDL-cholesterol response (P = 0.08) between the canola and polyunsaturated oil blends. Because the response between groups was not significantly different for the other lipoproteins, we also analyzed the pooled data for the baseline, butter, oil blend with TFAs, and TFA-free oil blend interventions (Table 4) .
In the pooled analysis, triacylglycerols were significantly elevated with the butter intervention compared with the TFA-free 244 NOAKES AND CLIFTON oil blends (P < 0.001). In both groups separately and in the pooled analysis, plasma total cholesterol was significantly elevated with the butter intervention compared with the baseline low-fat diet (P < 0.001). HDL cholesterol did not differ in either group, although when the data for the oil blends were pooled according to TFA content, TFA-free blends were associated with significantly higher HDL cholesterol than TFA-containing blends (P < 0.01). Plasma lipoprotein profiles after the baseline low-fat diets were not significantly different from those after any of the oil blend diets. However, ratios of total to HDL cholesterol after the TFA-free canola oil blend were significantly lower than at baseline (P = 0.005), whereas ratios after both TFA-free oil blends were significantly lower than after butter (P < 0.01). There was no difference in ratios of total to HDL cholesterol for the combined groups between the butter intervention and the baseline low-fat diet; only the TFA-free oil blends resulted in ratios that were significantly lower than those after the butter intervention (P < 0.001).
The magnitude of the LDL-cholesterol reduction between the butter intervention and the baseline low-fat diet or between the butter and canola or polyunsaturated oil blend interventions was not significantly different. There were no significant effects of sex or sex-by-diet interactions nor was there any correlation between the change in LDL cholesterol and baseline LDL values.
DISCUSSION
Our study showed that both the polyunsaturated and canola oil blends, which represent currently commercially available domestic margarines, lowered LDL cholesterol by 9-15% compared with butter in mildly hypercholesterolemic individuals, irrespective of whether the oil blends contained TFAs. This is consistent with other studies comparing butter and a highlinoleate TFA-free margarine (21) or butter and a high-oleic spread containing TFAs (22) . Our results are also in close agreement with the meta-analysis of Zock and Katan (23) , who showed that low-TFA tub margarines, similar to our TFA-containing oil blends, lowered total cholesterol relative to butter 0.25 mmol/L for every 10% of energy exchanged (23) . We observed a 0.53-0.70 mmol/L decrease in total cholesterol with a 20% energy exchange between butter and our margarines.
The higher-fat diets containing the oil blends were also as effective in lowering LDL-cholesterol concentrations as were the baseline low-fat diets that contained similar amounts of saturated fatty acids. Although the low-fat diet was not randomized within treatments, these data are consistent with the fact that it is the fatty acid composition rather than the amount of total fat that determines the LDL-cholesterol response (24). We did not observe a significant difference in HDL-cholesterol concentration between any of the interventions. The effect of TFAs has been reported to be dose related (9, 25) and the additional 2% of energy from TFAs contributed by the oil blends was possibly too small for detecting a difference within groups. When the groups were combined, however, TFA oil blends resulted in significantly lower HDL cholesterol than did the TFA-free blends, which is in keeping with the known effects of TFAs on lowering HDL cholesterol (7, 9) . The ratio of total to HDL cholesterol was significantly lower with the combined TFA-free blends than with butter. There were also no differences in the ratio of total to HDL cholesterol between butter, the oil blends with TFAs, and the baseline low-fat diet for the combined groups.
The significance of changes in ratios of LDL to HDL cholesterol in short-term intervention studies, however, is ambiguous. Whereas the ratio of total to HDL cholesterol generally increases with low-fat, high-carbohydrate diets under weight-maintenance conditions (26) , populations consuming such diets tend to have low rates of coronary artery disease (27) . Nevertheless, changes in the ratio of total to HDL cholesterol have been shown to be better predictors of risk for myocardial infarction than changes in LDL-cholesterol concentrations alone (28) . From our data, the change in risk from replacing 20% of energy from butter as soft margarine (either low-TFA or TFAfree) would be 34%, or half of this figure for a more realistic exchange of 10% of energy, which equates to 30 g spread. Although there was no statistically significant difference by our criteria in the ratio of total to HDL cholesterol between the oil blends with and without TFAs, we did observe a trend (P = 0.025) toward a lower ratio with the TFA-free blends.
Although the above-mentioned data are consistent with the known effects of dietary fatty acids on plasma lipid profiles, the observation that the TFA-free polyunsaturated oil blend lowered plasma LDL cholesterol a significant 6% more than did the TFAcontaining formulation was an unexpected finding. In the canola oil blend, 10% TFAs and 6% oleic acid were replaced by Ϸ10% C 12 to C 16 saturated fatty acids (6% lauric acid, 2% myristic acid, and 2% palmitic acid) plus a 2% increase in linoleic acid, the sum of which appeared to have a neutral effect. This is not consistent with the fact that TFAs are less potent than saturated fatty acids in elevating LDL cholesterol (29) . On the other hand, in the polyunsaturated blend, 10% TFAs and 5% linoleic were replaced by an 8% increase in C 12 to C 16 saturated fatty acids (6% lauric acid and 2% myristic acid) as well as 3% and 1% increases in oleic and linolenic acids, respectively. It has been observed in numerous meta-analyses that saturated fatty acids produce the greatest increment in total cholesterol and that PUFAs or MUFAs or both result in minor decreases (26, (30) (31) (32) . If TFAs had been included with saturated fatty acids, none of the formulas would have predicted a difference between oil blends, whereas the differences between the TFA blends and butter were much as expected.
On this basis, we would more likely have expected the TFAfree oil blends to give a neutral or less favorable total cholesterol response unless the interesterification process reduced the cholesterolemic effect of lauric and myristic acids. Although there is evidence that altering the positional distribution of palmitic acid does not alter its lipoprotein response (14, 15) , it is not known whether this is the case for lauric and myristic acids. One small trial showed that the randomization of the fatty acid positional distribution in butter, which is relatively high in lauric and myristic acids, resulted in lower cholesterolemia (33) . To put this argument in perspective, however, the blends provided only 20% of total energy and the absolute changes in individual dietary fatty acid intakes would be sufficiently small so as to make any lipid changes insignificant. Furthermore, the hard fraction of the oil blends, which contained the TFAs or interesterified fatty acids, represented only 25% of the blends. It is therefore unclear why the canola oil blends differed from the polyunsaturated oil blends, particularly because the hard fractions were similar, unless there was some interaction between TFAs and linoleic acid in the polyunsaturated oil blend. However, it must be pointed out that the 95% CI for the difference between the polyunsaturated oil blend with and without TFAs was large and that the LDL-cholesterol response between oil blends was not significantly different between groups. Although our results await confirmation, based on the differential total cholesterol reduction in the polyunsaturated oil blends, the potential coronary artery disease risk reduction would be 13% greater (33% compared with 20%) for the TFA-free polyunsaturated margarines than for their TFA-containing counterparts (34) . We conclude that, compared with butter, TFA-free margarines may be equal to or more effective than those containing TFAs in lowering LDL cholesterol and that this would have a substantial effect on coronary artery disease reduction.
